XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose adjusted budiodarone for the treatment of atrial fibrillation (AF), ...

XYRA gets US patent protecting use of dose adjusted budiodarone to treat AF, with monitoring to correspondingly reduce/delay risk of stroke and/or congestive heart failure: Los Al ...

A story from a hospital emergency room is going viral online. It shows how even one small tablet can sometimes change the way ...

A doctor recently shared a striking case from the emergency room that has sparked widespread discussion online. The story ...

A doctor shared a case where a 24-year-old was rushed to the ER with a heart rate of 212 after a night with friends.

A 35-year-old woman experienced cardiac arrest at a gym, her heart stopping for 17 minutes. She reported floating above her ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Reciting a poem or play, by synchronizing breath and heart rate to verse, has been found to reduce stress and relax the mind.

Former LSU walk-on Izzy Besselman was living the dream. Then she had to tackle a long, difficult medical ordeal.

In a significant advancement in cardiac care, specialists at Indraprastha Apollo Hospitals successfully performed a complex leadless pacemaker implantation in a 65-year-old patient with a metallic ...

The FDA has granted Fast Track designation to AFTX-201 for the treatment of BAG3-associated dilated cardiomyopathy.